Ninety-one men and 100 caregivers shared their thoughts on what worries them most when advanced prostate cancer becomes a way of life.
Understanding how patients' use their spiritual beliefs can help you determine which patients may be more likely to develop depressive symptoms.
A simple three-question survey has been developed to help clinicians identify women who may be experiencing symptoms of ovarian cancer.
One year after men undergo surgical removal of prostate cancer, they have significant anxiety, which appears to be linked to poor sexual satisfaction and depression.
Evidence points to a dose-response relation between radiation exposure of the pancreas and risk of diabetes in survivors of childhood cancers.
Ductal carcinoma in situ has a positive prognosis but requires treatment similar to that for invasive breast cancer, sending a conflicting message.
The clinical utility of a symptom index for ovarian cancer depends on precisely how it is used and how index-positive women are managed, indicate the results of a recent study.
Women with early-stage breast cancer often lacked knowledge about their disease and were not asked their preference regarding surgery, according to recent survey findings.
A new initiative launched by CDC is designed to reduce the risk of life-threatening infection in cancer patients undergoing chemotherapy.
A computer-based training program improved oncologists' responses to negative emotions expressed by patients with advanced cancer.
Postmenopausal women who have gained weight in adulthood are at greater risk of developing endometrial cancer than are women who maintain a stable weight, indicates a recent study.
A bedside assessment picked up symptoms and impairments that standard oncology assessments do not routinely identify in a group of older persons with acute myelogenous leukemia.
Quality-of-life (QoL) information from people with cancer is better obtained from online surveys than from paper forms—and even older patients appear to be willing to oblige.
A form of psychotherapy that is intended to relieve distress for dying patients and their families showed great effectiveness in a recent study.
Investigators in Spain have shown that a translation of the English-language Cancer Worry Scale is a valid and reliable scale for evaluating a healthy person's concern about cancer.
Palliative treatments, death outside of the hospital, and involvement by a palliative care team all improve the end-of-life experience for persons with head and neck cancer.
Patients with either breast symptoms or newly diagnosed breast cancer who completed a Web-based survey prior to their first clinic visit were highly satisfied with the experience.
Patients who are at high-risk for developing lung cancer can be identified through the use of a questionnaire, according to a study featured in the Journal of Thoracic Oncology (November 2009;4:1347-1351).
- Sexual Dysfunction in Women With Cancer: A Review of Available Interventions
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|